| Bioactivity | BGC 20-1531 (PGN 1531) hydrochloride is a potent and selective prostanoid EP4 receptor antagonist, with a pKb of 7.6. BGC 20-1531 hydrochloride has the potential for the research of migraine headache[1]. |
| Target | pKb: 7.6 (prostanoid EP4 receptor). |
| Name | BGC-20-1531 hydrochloride |
| CAS | 1962928-26-2 |
| Formula | C26H25ClN2O6S |
| Molar Mass | 529.00 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Maubach KA, et al. BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache. Br J Pharmacol. 2009;156(2):316-327. |
BGC-20-1531 hydrochloride
CAS: 1962928-26-2 F: C26H25ClN2O6S W: 529.00
BGC 20-1531 (PGN 1531) hydrochloride is a potent and selective prostanoid EP4 receptor antagonist, with a pKb of 7.6. BG
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.